SWM
EXAS

SVA Wealth Management’s Exact Sciences EXAS Stock Holding History

SVA Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$3.03M Sell
22,888
-9,549
-29% -$1.15M 0.26% 73
2020
Q3 		$3.31M Buy
32,437
+278
+0.9% +$24K 0.33% 63
2020
Q2 		$2.8M Buy
32,159
+500
+2% +$39.9K 0.3% 67
2020
Q1 		$1.84M Sell
31,659
-1,900
-6% -$154K 0.21% 84
2019
Q4 		$3.1M Buy
33,559
+285
+0.9% +$25.1K 0.28% 71
2019
Q3 		$3.01M Sell
33,274
-1,000
-3% -$114K 0.3% 72
2019
Q2 		$4.05M Sell
34,274
-5,000
-13% -$504K 0.4% 58
2019
Q1 		$3.4M Sell
39,274
-1,950
-5% -$166K 0.33% 71
2018
Q4 		$2.6M Sell
41,224
-200
-0.5% -$13.7K 0.29% 81
2018
Q3 		$3.27M Sell
41,424
-1,610
-4% -$105K 0.33% 67
2018
Q2 		$2.57M Buy
43,034
+1,141
+3% +$61.4K 0.28% 77
2018
Q1 		$1.97M Buy
41,893
+9
+0% +$439 0.24% 92
2017
Q4 		$2.2M Sell
41,884
-9
-0% -$481 0.26% 88
2017
Q3 		$1.97M Sell
41,893
-2,088
-5% -$84K 0.24% 92
2017
Q2 		$1.56M Sell
43,981
-825
-2% -$25.5K 0.2% 98
2017
Q1 		$1.06M Buy
44,806
+6,163
+16% +$122K 0.14% 103
2016
Q4 		$516K Sell
38,643
-1,500
-4% -$24.2K 0.08% 137
2016
Q3 		$745K Sell
40,143
-7,750
-16% -$137K 0.12% 117
2016
Q2 		$587K Sell
47,893
-648
-1% -$4.88K 0.09% 130
2016
Q1 		$327K Hold
48,541
– – 0.05% 165
2015
Q4 		$448K Buy
48,541
+6,358
+15% +$59.1K 0.08% 161
2015
Q3 		$759K Buy
42,183
+5,300
+14% +$122K 0.14% 131
2015
Q2 		$1.1M Sell
36,883
-750
-2% -$18.8K 0.2% 112
2015
Q1 		$829K Buy
37,633
+16,418
+77% +$417K 0.15% 131
2014
Q4 		$582K Sell
21,215
-100
-0.5% -$2.43K 0.21% 107
2014
Q3 		$413K Sell
21,315
-950
-4% -$17.4K 0.18% 109
2014
Q2 		$379K Sell
22,265
-700
-3% -$9.64K 0.16% 114
2014
Q1 		$325K Buy
22,965
+5,965
+35% +$80.6K 0.15% 118
2013
Q4 		$200K Buy
+17,000
New +$195K 0.12% 128

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

SVA Wealth Management's EXAS Position: Q4 2020 in Review

SVA Wealth Management reduced its Exact Sciences (EXAS) stake by 29% in Q4 2020, selling an estimated $1.15M and leaving 22,888 shares worth $3.03M. The position accounts for 0.26% of the portfolio, ranked #73.

SVA Wealth Management first reported a position in EXAS in Q4 2013 and has held it in 29 quarters since. The position peaked at $4.05M in Q2 2019. 621 funds tracked by Wall St. Rank hold EXAS as of Q4 2020.

  • SVA Wealth Management held 22,888 shares of Exact Sciences worth $3.03M as of Q4 2020.
  • SVA Wealth Management sold 9,549 Exact Sciences shares in Q4 2020, an estimated $1.15M.
  • Exact Sciences made up 0.26% of SVA Wealth Management's portfolio in Q4 2020, its #73 holding.
  • SVA Wealth Management first reported a position in Exact Sciences in Q4 2013 and has held it in 29 quarters since.
  • SVA Wealth Management's Exact Sciences position peaked at $4.05M in Q2 2019.
  • 621 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2020.

Based on SVA Wealth Management's 13F filing for Q4 2020, filed 4 Feb 2021.